|
|
Microfabrication of a micron-scale microbial-domestication pod for cultivation of marine bacteria. |
Christopher Cartmell |
|
1995 |
Detecting differences in 5-methylcytosine using restriction enzyme isoschizomers: an endogenous control for complete digestion. |
|
|
2001 |
cDNA microarray analysis of multidrug resistance: doxorubicin selection produces multiple defects in apoptosis signaling pathways. |
|
|
2001 |
Laminin-5-mediated gene expression in human prostate carcinoma cells. |
|
|
2002 |
Development and molecular characterization of HCT-116 cell lines resistant to the tumor promoter and multiple stress-inducer, deoxycholate. |
|
|
2002 |
Diverse actions of ovarian steroids in the serotonin neural system. |
John M. Streicher, PhD |
|
2002 |
Water quality has a pronounced effect on cholesterol-induced accumulation of Alzheimer amyloid beta (Abeta) in rabbit brain. |
Jeffrey J. Lochhead, PhD |
|
2003 |
Low-level arsenite induced gene expression in HEK293 cells. |
|
|
2003 |
Mutant p53 and aberrant cytosine methylation cooperate to silence gene expression. |
|
|
2004 |
The acetyltransferase p300/CBP-associated factor is a p53 target gene in breast tumor cells. |
|
|
2004 |
Performance evaluation of commercial short-oligonucleotide microarrays and the impact of noise in making cross-platform correlations. |
|
|
2004 |
Proteasome-dependent degradation of cytochromes P450 2E1 and 2B1 expressed in tetracycline-regulated HeLa cells. |
John M. Streicher, PhD |
|
2004 |
The chemopreventive agent alpha-difluoromethylornithine blocks Ki-ras-dependent tumor formation and specific gene expression in Caco-2 cells. |
|
|
2005 |
Serotonin-related gene expression in female monkeys with individual sensitivity to stress. |
John M. Streicher, PhD |
|
2005 |
Water Quality and Cholesterol-induced pathology: differential effects of the M-1 muscarinic receptor agaonist AF267b on accumulation of Alzheimer-like Amyloid B in rabbit brain |
Jeffrey J. Lochhead, PhD |
|
2005 |
Atorvastatin therapy lowers circulating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate AD. |
Jeffrey J. Lochhead, PhD |
|
2005 |
Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results. |
Jeffrey J. Lochhead, PhD |
|
2006 |
AP-2alpha and AP-2gamma are transcriptional targets of p53 in human breast carcinoma cells. |
|
|
2006 |
Epigenetic inactivation of the HOXA gene cluster in breast cancer. |
|
|
2006 |
Pharmacogenomics of the polyamine analog 3,8,13,18-tetraaza-10,11-[(E)-1,2-cyclopropyl]eicosane tetrahydrochloride, CGC-11093, in the colon adenocarcinoma cell line HCT1161. |
|
|
2007 |
Profiling of selenomethionine responsive genes in colon cancer by microarray analysis. |
|
|
2007 |
Identification of Fn14/TWEAK receptor as a potential therapeutic target in esophageal adenocarcinoma. |
|
|
2008 |
Progesterone and estrogen regulate oxidative metabolism in brain mitochondria. |
Roberta Diaz Brinton, Ph.D |
|
2008 |
The role of COX-2 in heart pathology. |
John M. Streicher, PhD |
|
2008 |
Novel D-amino acid tetrapeptides produce potent antinociception by selectively acting at peripheral kappa-opioid receptors. |
Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD |
